Intravenous Dexmedetomidine for Treatment of Shivering During Cesarean Section Under Neuraxial Anesthesia

• Status: Completed
• Trial end date: 2016-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether dexmedotomidine is effective in the treatment of shivering associated with neuraxial anesthesia during cesarean delivery.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: St. Justine's Hospital
• Treatments: Anesthetics; Dexmedetomidine

Criteria

Inclusion Criteria:

• Cesarean delivery under neuraxial anesthesia (epidural or spinal) planned or unplanned between 8 am and 8 pm on week days when one of the investigator is present.

• Participants with fever or shivering before the cesarean section are include

Exclusion Criteria:

• No comprehension of french or english language

• Urgent cesarean delivery for non reassuring fetal tracing

• Extremely urgent cesarean delivery (grade 1)

• Weight < 60 kg ou > 120 kg

• Hypersensibility to dexmedetomidine

• Heart, renal or hepatic disease requiring follow up, medication or with a possibility of instability during cesarean delivery

• Pre-eclampsia

• Combined spinal-epidural anesthesia

• Conversion into general anesthesia

• Blood products transfusions or major complications during surgery